SOCS1 and thyroid gland carcinoma: Given the oncogenic nature of JAK/STAT pathway in different human cancers [102] including thyroid carcinomas [103], targeting miR-155 could inhibit the thyroid cancer development/progression via activating SOCS1 and suppressing JAK/STAT.